51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04789850 (ClinicalTrials.gov)	February 2, 2023	10/2/2021	Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis	Safety and Efficacy of Itacitinibin Adults With Systemic Sclerosis: a Phase II, Randomized, Controll ...	Systemic Sclerosis	Drug: Itacitinib;Drug: Placebo	Assistance Publique - Hôpitaux de Paris	NULL	Recruiting	18 Years	N/A	All	74	Phase 2	France
2	EUCTR2019-003430-16-FR (EUCTR)	28/07/2020	02/06/2020	Safety and efficacy of itacitinib in adults with systemic sclerosis	Safety and efficacy of itacitinibin adults with systemic sclerosis: a phase II, randomized, controll ...	Patients with newly or active diffuse Systemic sclerosis (SSc) at the time of screening MedDRA versi ...	Product Name: Itacitinib Product Code: INCB039110 INN or Proposed INN: ITACITINIB	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	74	Phase 2	France

First Previous1Next Last